ANTHEM
Anthem Biosciences Limited
Biotechnology · ₹42,327 Cr market cap
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
2
Tracked investors holding
20
Tracked moves
₹752
Share price
Latest activity
Premji InvestNew position
Premji Invest bought 8,05,586 shares of Anthem Biosciences for ₹60.00 crore at ₹744.80 apiece in a block deal. This was part of a larger transaction where promoter Aruna Ganesh sold a 3.05% stake in the company and fully exited.
Top investors holding Anthem Biosciences Limited
2.35%
1.64%
Track smart money in Anthem Biosciences Limited
Get alerted when a top investor buys or sells.
Get started